Navigating the U.S. Regulatory Landscape for Neurologic Digital Health Technologies
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Huntsman D, Bulaj G Int J Environ Res Public Health. 2025; 22(2).
PMID: 40003451 PMC: 11855921. DOI: 10.3390/ijerph22020225.
References
1.
Abramoff M, Roehrenbeck C, Trujillo S, Goldstein J, Graves A, Repka M
. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit Med. 2022; 5(1):72.
PMC: 9184542.
DOI: 10.1038/s41746-022-00621-w.
View
2.
Tang M, Nakamoto C, Stern A, Zubizarreta J, Marcondes F, Uscher-Pines L
. Effects of Remote Patient Monitoring Use on Care Outcomes Among Medicare Patients With Hypertension : An Observational Study. Ann Intern Med. 2023; 176(11):1465-1475.
DOI: 10.7326/M23-1182.
View
3.
Sotirakis C, Su Z, Brzezicki M, Conway N, Tarassenko L, FitzGerald J
. Identification of motor progression in Parkinson's disease using wearable sensors and machine learning. NPJ Parkinsons Dis. 2023; 9(1):142.
PMC: 10560243.
DOI: 10.1038/s41531-023-00581-2.
View
4.
Clark P, Kim J, Aphinyanaphongs Y
. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review. JAMA Netw Open. 2023; 6(7):e2321792.
PMC: 10323702.
DOI: 10.1001/jamanetworkopen.2023.21792.
View
5.
Shah N, Mello M
. Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration. JAMA Netw Open. 2023; 6(7):e2321753.
DOI: 10.1001/jamanetworkopen.2023.21753.
View